Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.09.16
关于“19海普01”回售申报情况的公告
2020.09.14
关于“19海普01”票面利率调整暨投资者回售实施办法第三次提示性公告
2020.09.10
关于“19海普01”票面利率调整暨投资者回售实施办法第二次提示性公告
2020.09.08
关于“19海普01”票面利率调整暨投资者回售实施办法第一次提示性公告
2020.09.04
关于拟下调“19海普01”公司债券票面利率的提示性公告
2020.09.01
第五届董事会第一次会议决议公告
2020.09.01
关于聘任董事会秘书和证券事务代表的公告
2020.09.01
第五届监事会第一次会议决议公告
2020.09.01
关于选举职工代表监事的公告
2020.09.01
2020年第三次临时股东大会的法律意见书
第一页
上一页
25
26
27
28
29
下一页
最后一页
